Cadrenal Therapeutics Inc (CVKD)

Currency in USD
10.8000
+0.2200(+2.08%)
Real-time Data·
CVKD Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CVKD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10.150110.9900
52 wk Range
5.700022.9011
Key Statistics
Prev. Close
10.58
Open
10.49
Day's Range
10.1501-10.99
52 wk Range
5.7-22.9011
Volume
10.51K
Average Volume (3m)
29.18K
1-Year Change
70.49%
Book Value / Share
3.25
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CVKD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
35.6667
Upside
+230.25%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Cadrenal Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Cadrenal Therapeutics Inc Company Profile

Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions. The company is developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, atrial fibrillation, and thrombotic anti-phospholipid syndrome. It has a collaboration agreement with Abbott Global Enterprises Limited to evaluate the efficacy and safety of Tecarfarin in patients with a left-ventricular assist device. Cadrenal Therapeutics, Inc. was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.

Compare CVKD to Peers and Sector

Metrics to compare
CVKD
Peers
Sector
Relationship
P/E Ratio
−1.7x−5.3x−0.5x
PEG Ratio
0.02−0.010.00
Price/Book
3.7x2.5x2.6x
Price / LTM Sales
-1.4x3.3x
Upside (Analyst Target)
193.8%87.4%43.4%
Fair Value Upside
Unlock16.1%7.1%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 35.6667
(+230.25% Upside)

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
-- / -1.26
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CVKD Income Statement

People Also Watch

247.19
AVAV
-4.78%
18.27
SRPT
+1.75%
9.0000
ARTL
-0.33%
5.5500
BGLC
-1.94%
9.050
CAPR
+12.14%

FAQ

What Stock Exchange Does Cadrenal Therapeutics Trade On?

Cadrenal Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Cadrenal Therapeutics?

The stock symbol for Cadrenal Therapeutics is "CVKD."

What Is the Cadrenal Therapeutics Market Cap?

As of today, Cadrenal Therapeutics market cap is 21.66M.

What Is Cadrenal Therapeutics's Earnings Per Share (TTM)?

The Cadrenal Therapeutics EPS (TTM) is -9.08.

When Is the Next Cadrenal Therapeutics Earnings Date?

Cadrenal Therapeutics will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is CVKD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Cadrenal Therapeutics Stock Split?

Cadrenal Therapeutics has split 1 times.

How Many Employees Does Cadrenal Therapeutics Have?

Cadrenal Therapeutics has 4 employees.

What is the current trading status of Cadrenal Therapeutics (CVKD)?

As of 08 Aug 2025, Cadrenal Therapeutics (CVKD) is trading at a price of 10.80, with a previous close of 10.58. The stock has fluctuated within a day range of 10.15 to 10.99, while its 52-week range spans from 5.70 to 22.90.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.